Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Masaki Sanekata"'
Autor:
Shingo Ishii, Masaki Sanekata, Yasuyuki Ariyasu, Takayoshi Yoshikawa, Yumiko Itoh, Jingoro Shimada, Takuji Komeda
Publikováno v:
Journal of Infection and Chemotherapy. 21:194-201
Peramivir is the only intravenous formulation among anti-influenza neuraminidase inhibitors currently available. Peramivir was approved for manufacturing and marketing in Japan in January 2010. In October 2010, an additional indication for pediatric
Autor:
Takuji, Komeda, Shingo, Ishii, Yumiko, Itoh, Yasuyuki, Ariyasu, Masaki, Sanekata, Takayoshi, Yoshikawa, Jingoro, Shimada
Publikováno v:
Journal of Infection and Chemotherapy. 20:689-695
Peramivir is the only intravenous formulation among anti-influenza neuraminidase inhibitors currently available. Peramivir was approved for manufacturing and marketing in Japan in January 2010. We conducted a drug use investigation of peramivir from
Autor:
Tetsuro Fujita, Patrick J. Rudewicz, Akira Iida, Michiko Kanai, Eiichi Tachikawa, Goro Fuse, Akio Enoki, Masaki Sanekata, Hiromi Tanaka
Publikováno v:
Chemical and Pharmaceutical Bulletin. 42:1070-1075
New peptaibols, trichokindins I-VII, have been isolated from the fungus Trichoderma harzianum. Their structures were characterized by spectrometric methods. Trichokindins, which are 18-residue peptides containing one to three isovaline residues, were
Publikováno v:
Chemical and Pharmaceutical Bulletin. 38:2997-3003
The antibiotic icosapeptide trichosporin B-V, which was isolated from Trichoderma polysporum, was synthesized by assembling five peptide fragments via the N, N7'-dicyclohexylcarbodimide method. The synthesized peptide was identical with the natural o
Autor:
Akira Iida, Tetsuro Fujita, Michiko Kanai, Hiromi Tanaka, Goro Fuse, Shun-ichi Wada, Akio Enoki, Masaki Sanekata, Koji Asami
Publikováno v:
Chemicalpharmaceutical bulletin. 43(3)
New membrane-modifying peptides, trichorozing I-IV, have been isolated from conidia of the fungus Trichoderma harzianum. Their amino acid sequences were clearly determined by spectrometric methods and, furthermore, they were synthesized by the soluti
Autor:
Shingo Ishii, Masaki Sanekata, Jingoro Shimada, Takayoshi Yoshikawa, Yumiko Itoh, Takuji Komeda
Publikováno v:
Journal of Infection and Chemotherapy. (10):677-684
Peramivir, the only injectable anti-influenza neuraminidase inhibitor medically available in Japan at present, is considered first-line treatment in patients with high risk factors for influenza exacerbation. We conducted a drug-use investigation of